About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETED

Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites

NCT03200106•Sequana Medical N.V.

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Malignant Ascites

Interventions

Alfapump

Locations

3

Germany

Locations (3)

Universitätsklinikum Leipzig

Leipzig, Germany

Inselspital

Bern, Switzerland

Hammersmith Hospital

London, United Kingdom

Key Dates

Start Date

August 1, 2017

Primary Completion Date

February 28, 2018

Completion Date

March 31, 2018

Last Updated

April 9, 2018

Related Studies

RECRUITINGPhase 1

Tocilizumab Delivered Via Pleural and Peritoneal Catheters in Patients With Advanced Metastatic Cancer

NCT06016179

Malignant Pleural EffusionMalignant Ascites

Active Not RecruitingPhase 2

Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02122185

Brenner TumorMalignant Ascites+26 more

Oncolytic Virotherapy Plus PD-1 Inhibitor for Patients With Refractory Malignant Ascites

NCT05303844

Refractory Malignant Ascites

Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology

NCT02477657

Refractory Malignant Ascites

COMPLETEDPhase 2

Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites

NCT00326885

Malignant Ascites

UNKNOWNPhase 1/2

Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites

NCT03230708

Malignant Ascites

View all related studies

Sponsors

Lead Sponsor

Sequana Medical N.V.

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 9, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions